STRATEC Biomedical(GB:0RAR)
€27.80+0.80 (+2.96%)
GB:0RAR
STRATEC Biomedical Revenue
€27.80
At close:+0.80 (+2.96%)
STRATEC Biomedical (0RAR) Revenue
1 Followers
STRATEC Biomedical Revenue
STRATEC Biomedical had a revenue of 52.37M in the quarter ending Sep 30, 2026, with -11.40%. This bring the company's revenue in the last twelve months to 240.18M, Decreased 1.89%. In the fiscal year ending Mar 31, 2026, STRATEC Biomedical had annual revenue of 250.86M with -2.62% growth.
- Revenue (ttm)
- 240.18M
- Revenue Growth
- ―
- P/S Ratio
- 1.35
- Revenue/Employee
- EUR 181,390
- Employees
- 1,383
- Market Cap
- EUR 339.15M
Revenue Chart
STRATEC Biomedical Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 250.86M | -6.76M | -2.62% |
| Mar 31, 2025 | 257.62M | -12.79M | -4.73% |
| Dec 31, 2023 | 270.41M | -4.21M | -1.53% |
| Dec 31, 2022 | 274.63M | -12.71M | -4.42% |
| Dec 31, 2021 | 287.33M | 37.24M | 14.89% |
| Mar 31, 2021 | 250.10M | 28.46M | 12.84% |
| Mar 31, 2020 | 221.64M | 33.82M | 18.01% |
| Mar 31, 2019 | 187.82M | -21.95M | -10.46% |
| Dec 31, 2017 | 209.76M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.